Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa - PR Newswire

/PRNewswire/ -- The South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, '4-in-1' fixed-dose combination of...

CAPE TOWN, South Africa and MUMBAI, India  , June 14, 2022 /PRNewswire/ -- The South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, '4-in-1' fixed-do… [+7039 chars]

full article...